
HGYN does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for HGYN and 80,000+ other tickers.
See exactly how HGYN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HGYN and 80,000+ other tickers.
Hong Yuan Holding Group presently conducts no substantial business operations. Historically, the company's primary focus lay in the advancement and commercialization of bio-derived resins. It operated under the name Cereplast, Inc. until June 2021, when it officially adopted its current designation. Established in 2001, the entity's headquarters are situated in Zhengzhou, China.
No recent news available.